Ingenia Therapeutics Inc. (KOSDAQ:950260)
South Korea · Delayed Price · Currency is KRW 18,470
+540 (3.01%)
At close: Sep 18, 2026
Ingenia Therapeutics Revenue
Ingenia Therapeutics had revenue of 7.42B KRW in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 7.42B.
Revenue (ttm)
7.42B
Revenue Growth
n/a
P/S Ratio
123.09
Revenue / Employee
370.96M
Employees
20
Market Cap
913.24B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 3.53B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.